{"disease":{"id":"pole-exonuclease-mutant-colon-cancer","name":"pole exonuclease mutant colon cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03827044","title":"Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":30,"lead_sponsor_name":"Royal Marsden NHS Foundation Trust","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}